HK Stock Connect Daily Report: Pharmaceutical Sector Explodes Across the Board, EVEREST MED Surges 41%! KUAISHOU-W Drops 11% After Results - 20260820

NewTimeSpace · 2026/08/20 17:51 · By Zeyu Wu

On August 20, the three major Hong Kong indices rose in tandem. The Hang Seng Index gained 0.8% to 25,698.49 points and the Hang Seng TECH Index rose 0.39%, with turnover at HKD 269.1 billion. The success of the world's first mRNA cancer vaccine Phase III clinical trial ignited the pharmaceutical sector, with EVEREST MED surging 41.43% and GENSCRIPT BIO up 13.62%. Gold stocks advanced, with ZIJIN GOLD INTL up 11.25%. Automakers recovered broadly, with LI AUTO-W up 5.53%. Southbound capital recorded a net sell of HKD 10.412 billion. KUAISHOU-W posted Q2 adjusted net profit of RMB 3.9 billion with Kling AI revenue up over 200% year-on-year, but its shares fell 11%. SIMCERE PHARMA issued a positive profit alert, and Junlebao Dairy Group filed with HKEX.

I. Market Overview

On August 20, the three major Hong Kong indices rose in tandem. The Hang Seng Index gained 0.8% to 25,698.49 points; the Hang Seng TECH Index rose 0.39%; and the Hang Seng China Enterprises Index rose 0.90%. Full-day turnover was HKD 269.119 billion, up from the previous trading day.

On the market, the success of the world's first mRNA cancer vaccine Phase III clinical trial ignited the pharmaceutical sector: EVEREST MED (01952.HK) surged 41.43%, GENSCRIPT BIO (01548.HK) rose 13.62%, and METIS TECHBIO-P (07666.HK) rose 27.99%. Gold stocks advanced again, with ZIJIN GOLD INTL (02259.HK) up 11.25% and LINGBAO GOLD (03330.HK) up 5.99%. Automakers recovered broadly, with LI AUTO-W (02015.HK) up 5.53% and NIO-SW (09866.HK) up 4.49%. Paper stocks led the declines, with ND PAPER (02689.HK) down 16.8%; KUAISHOU-W (01024.HK) fell 11.0%.

Southbound capital recorded a net sell of HKD 10.412 billion on the day. Within that, Stock Connect (Shanghai) saw a net sell of HKD 5.111 billion and Stock Connect (Shenzhen) a net sell of HKD 5.301 billion.

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainer 1	01952.HK	EVEREST MED	41.43	33.66	42.69
Gainer 2	06185.HK	CANSINOBIO	37.36	32.06	13.94
Gainer 3	02706.HK	HAIZHI TECH GP	15.19	44.60	3.50
Gainer 4	01548.HK	GENSCRIPT BIO	13.62	33.36	37.88
Gainer 5	01177.HK	SBP GROUP	12.53	5.39	21.10
Loser 5	00667.HK	CHINA EAST EDU	-9.32	3.94	1.36
Loser 4	01276.HK	HENGRUI PHARMA	-9.63	49.66	14.31
Loser 3	01024.HK	KUAISHOU-W	-11.01	33.64	84.36
Loser 2	02013.HK	WEIMOB INC	-13.51	0.96	1.88
Loser 1	02689.HK	ND PAPER	-16.80	6.59	7.51

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	09988.HK	ALIBABA-W	62.20	22.05	1.61
2	01952.HK	EVEREST MED	47.89	-3.18	41.43
3	00700.HK	TENCENT	40.21	-4.09	0.94
4	01024.HK	KUAISHOU-W	40.07	11.44	-11.01
5	00981.HK	SMIC	32.91	-3.51	-1.23
6	01548.HK	GENSCRIPT BIO	28.44	2.06	13.62
7	02800.HK	Tracker Fund Of Hong Kong	27.62	-27.59	0.85
8	01810.HK	XIAOMI-W	27.57	-0.22	1.17
9	02513.HK	Z.AI	21.45	0.01	1.09
10	00100.HK	MINIMAX-W	18.43	-0.45	6.16

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainer 1	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	5.59	12.36
Gainer 2	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	5.20	13.14
Gainer 3	159567	Yinhua CNI HK Equities Innovative Drugs ETF	5.19	23.49
Gainer 4	520970	Harvest CSI HK Equities Innovative Drugs ETF	5.16	2.62
Gainer 5	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	5.14	11.36
Loser 5	/	/	/	/
Loser 4	/	/	/	/
Loser 3	159568	Bosera CSI HK Equities Internet ETF	-0.09	0.79
Loser 2	520910	ChinaAMC CSI HK Equities Internet ETF	-0.15	0.42
Loser 1	159010	Bosera Hang Seng HK Technology Theme ETF	-0.54	0.07

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	45.09	17.23	5.08
2	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	23.49	29.42	5.19
3	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	17.25	25.17	4.81
4	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index (RMB)	14.42	63.44	0.74
5	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	14.29	3.52	0.51
6	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	13.14	41.40	5.20
7	159506	Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF	Hang Seng HK Equities Innovative Drugs And Health Care Index	12.36	36.19	5.59
8	159217	ICBCCS CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	11.36	15.07	5.14
9	520700	Wanjia CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	9.59	120.49	5.08
10	520880	Hwabao WP Hang Seng HK Innovative Drugs Selected ETF	Hang Seng HK Innovative Drugs Selected Index	9.03	38.32	5.10

IV. Industry and Corporate Updates

1. KUAISHOU-W posts Q2 adjusted net profit of RMB 3.9 billion; Kling AI revenue up over 200% year-on-year

After market close on August 19, KUAISHOU-W (01024.HK) disclosed its second-quarter 2026 results. Second-quarter total revenue was RMB 35.5 billion, up 1.4% year-on-year; adjusted net profit was RMB 3.9 billion, with an adjusted net profit margin of 11.0%. First-half total revenue was RMB 69.251 billion, up 2.4% year-on-year; adjusted net profit was RMB 7.287 billion. Average daily active users reached 412.3 million in the second quarter, a record high. Kling AI generated revenue of over RMB 850 million, up over 200% year-on-year. KUAISHOU-W is a Stock Connect constituent.

2. SIMCERE PHARMA issues positive interim profit alert, expecting first-half profit attributable to owners up 34.8%–43.1%

On August 20, SIMCERE PHARMA (02096.HK) issued a positive profit alert, expecting first-half revenue of RMB 4.55 billion to RMB 4.61 billion, up approximately 26.9%–28.6% year-on-year; profit attributable to owners of approximately RMB 810 million to RMB 860 million, up approximately 34.8%–43.1% year-on-year; and adjusted net profit attributable to owners of approximately RMB 950 million to RMB 1.0 billion, up approximately 46.5%–54.2% year-on-year. The growth mainly benefits from the rising share of innovative drug revenue and contributions from BD out-licensing income. SIMCERE PHARMA will hold an interim results briefing on August 21. SIMCERE PHARMA is a Stock Connect constituent.

3. ND PAPER issues positive profit alert, expecting full-year profit attributable to shareholders up 92.4%–103.7%

Around midday on August 20, ND PAPER (02689.HK) issued a positive profit alert, expecting profit of approximately RMB 3.9 billion to RMB 4.1 billion for the year ended June 2026, up 77.1%–86.2% year-on-year; profit attributable to equity holders of the company of approximately RMB 3.4 billion to RMB 3.6 billion, up 92.4%–103.7% year-on-year. The growth was mainly driven by higher sales volumes, with product price increases clearly outpacing raw material cost rises. ND PAPER is a Stock Connect constituent.

4. DONGGUANG CHEM issues positive profit alert, expecting interim net profit up about 55%

On August 19, DONGGUANG CHEM (01702.HK) issued a positive profit alert, expecting net profit for the six months ended June 2026 to increase by approximately 55% year-on-year, mainly due to higher revenue driving up overall gross profit and gross margin, as well as gains from urea futures hedging. DONGGUANG CHEM is a Stock Connect constituent.

5. Junlebao Dairy Group files listing application with HKEX, planning Hong Kong listing

On August 20, according to HKEX filings, Junlebao Dairy Group Co., Ltd. has submitted a main board listing application to HKEX, with CICC and Morgan Stanley as joint sponsors. Junlebao is a leading comprehensive dairy enterprise in China, with a business covering all categories including infant formula, ambient milk and chilled milk. The company first filed on January 19 2026, and this submission follows an updated prospectus.

V. Market Notes

Eligible securities list adjustment announcement

No new announcements.

Trading calendar

No approaching market closure days.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

HK Stock Connect Daily Report EVEREST MED Alibaba-W Fullgoal Hang Seng HK Equities Innovative Drugs And Health Care ETF China Universal CNI HK Equities Innovative Drugs ETF